Synergistic Cytotoxic and Apoptotic Effects of Local Probiotic Lactobacillus Brevis Isolated from Regional Dairy Products in Combination with Tamoxifen

References

• Bray F, Ferlay J, Soerjomataram I, Siegel R, Torre L, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clinicians. 2018; 68(6): 394-424. doi:10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Dai X, Li T, Bai Z, Yang Y, Liu X, Zhan J, Shi B. Breast cancer intrinsic subtype classification, clinical use and future trends. Am. J Cancer Res. 2015;5(10):2929–43.
   PubMed Web of Science ®Google Scholar
• Katchy A, Williams C. Profiling of estrogen-regulated microRNAs in breast cancer cells. JoVE. 2014;(84) doi:10.3791/51285
   Google Scholar
• Frankfurt O, Sugarbaker E, Robb J, Villa L. Synergistic induction of apoptosis in breast cancer cells by tamoxifen and calmodulin inhibitors. Cancer Lett. 1995;97(2):149–54. doi:10.1016/0304-3835(95)03970-8
   PubMed Web of Science ®Google Scholar
• Jin Y, Desta Z, Stearns V, Ward B, Ho H, Lee K-H, Skaar T, Storniolo AM, Li L, Araba A, et al. CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J National Cancer Inst. 2005;97(1):30–9. doi:10.1093/jnci/dji005
   PubMed Web of Science ®Google Scholar
• Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI: J National Cancer Inst. 1998;90(18):1371–88. doi:10.1093/jnci/90.18.1371
   Web of Science ®Google Scholar
• Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339(22):1609–18. doi:10.1056/NEJM199811263392207
   PubMed Web of Science ®Google Scholar
• Schroth W, Goetz MP, Hamann U, Fasching P, Schmidt M, et al. Association between CYP2D6 polymorphisms and outcomes among women with early stage breast cancer treated with tamoxifen. Jama. 2009;302(13):1429–36. doi:10.1001/jama.2009.1420
   PubMed Web of Science ®Google Scholar
• Leung E, Kannan N, Krissansen G, Findlay M, Baguley B. MCF-7 breast cancer cells selected for tamoxifen resistance acquire new phenotypes differing in DNA content, phospho-HER2 and PAX2 expression, and rapamycin sensitivity. Cancer Biol Ther. 2010;9(9):717–24. doi:10.4161/cbt.9.9.11432
   PubMed Web of Science ®Google Scholar
• Braden A, Stankowski R, Engel J, Onitilo A. Breast cancer biomarkers: risk assessment, diagnosis, prognosis, prediction of treatment efficacy and toxicity, and recurrence. CPD. 2014;20(30):4879–98. doi:10.2174/1381612819666131125145517
   Google Scholar
• Wiebe V, Osborne CK, Fuqua SA, DeGregorio MW. Tamoxifen resistance in breast cancer. Crit. Rev. Oncol Hematol. 1993;14(3):173–88. doi:10.1016/1040-8428(93)90008-R
   PubMed Web of Science ®Google Scholar
• Yazdi MH, Mahdavi M, Kheradmand E, Shahverdi AR. The preventive oral supplementation of a selenium nanoparticle-enriched probiotic increases the immune response and lifespan of 4T1 breast cancer bearing mice. Arzneim-Forsc. 2012;62(11):525–31. doi:10.1055/s-0032-1323700
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Daillère R, Roberti M, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nat Rev Microbiol. 2017;15(8):465–78. doi:10.1038/nrmicro.2017.44
   PubMed Web of Science ®Google Scholar
• Pandey K, Naik S, Vakil B. Probiotics, prebiotics and synbiotics-a review. J Food Sci Technol. 2015;52(12):7577–87. doi:10.1007/s13197-015-1921-1
   PubMed Web of Science ®Google Scholar
• Grangette C, Nutten S, Palumbo E, Morath S, Hermann C, Dewulf J, Pot B, Hartung T, Hols P, Mercenier A. Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids. Proc. National Acad. Sci. 2005;102(29):10321–6. doi:10.1073/pnas.0504084102
   PubMed Web of Science ®Google Scholar
• Kishi A, Uno K, Matsubara Y, Okuda C, Kishida T. Effect of the oral administration of Lactobacillus brevis subsp. coagulans on interferon-alpha producing capacity in humans. J Am Coll Nutr. 1996;15(4):408–12. doi:10.1080/07315724.1996.10718617
   PubMed Web of Science ®Google Scholar
• Niazi Amraii H, Abtahi H, Jafari P, Mohajerani HR, Fakhroleslam MR, Akbari N. In Vitro study of Potentially Probiotic lactic Acid Bacteria Strains Isolated From Traditional Dairy Products. Jundishapur J Microbiol. 2014;7(6):e10168. doi:10.5812/jjm.10168
   PubMed Web of Science ®Google Scholar
• Karami S, Roayaei M, Hamzavi H, Bahmani M, Hassanzad-Azar H. Isolation and identification of probiotic Lactobacillus from local dairy and evaluating their antagonistic effect on pathogens. Int J Pharma Investig. 2017;7(3):137. doi:10.4103/jphi.JPHI_8_17
   PubMed Web of Science ®Google Scholar
• Anderson R, Cookson A, McNabb W, Kelly W, Roy N. Lactobacillus plantarum DSM 2648 is a potential probiotic that enhances intestinal barrier function. FEMS Microbiol Lett. 2010;309(2):184–92. doi:10.1111/j.1574-6968.2010.02038.x
   PubMed Web of Science ®Google Scholar
• Kumar A, Kumar D. Characterization of Lactobacillus isolated from dairy samples for probiotic properties. Anaerobe. 2015;33:117–23. doi:10.1016/j.anaerobe.2015.03.004
   PubMed Web of Science ®Google Scholar
• Hosseini SV, Arlindo S, Böhme K, Fernández-No C, Calo-Mata P, Barros-Velázquez J. Molecular and probiotic characterization of bacteriocin‐producing Enterococcus faecium strains isolated from nonfermented animal foods. J Appl. Microbiol. 2009;107(4):1392–403. doi:10.1111/j.1365-2672.2009.04327.x
   PubMed Web of Science ®Google Scholar
• Ahmed M, Hafez E, Mkamer M, ElAbdelrrassoul H, Mabrouk Y. Application of DNA technology to detect food infection with some pathogenic bacteria using 16S rDNA gene, PCR-RFLP and sequencing. J Food, Agric. Environ. (JFAE). 2014;12(2):202–6.
   Google Scholar
• Biffi A, Coradini D, Larsen R, Riva L, Di Fronzo G. Antiproliferative effect of fermented milk on the growth of a human breast cancer cell line. Nutr. Cancer. 1997;28(1):93–9. doi:10.1080/01635589709514558
   PubMed Web of Science ®Google Scholar
• Lee JH, Nam SH, Seo WT, Yun HD, Hong SY, Kim MK, Cho KM. The production of surfactin during the fermentation of cheonggukjang by potential probiotic Bacillus subtilis CSY191 and the resultant growth suppression of MCF-7 human breast cancer cells. Food Chem. 2012;131(4):1347–54. doi:10.1016/j.foodchem.2011.09.133
   Web of Science ®Google Scholar
• Chou T-C. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70(2):440-6. doi:10.1158/0008–5472.
   PubMed Web of Science ®Google Scholar
• Mandlekar S, Kong A. Mechanisms of tamoxifen-induced apoptosis. Apoptosis. 2001;6(6):469–77. doi:10.1023/A:1012437607881
   PubMed Web of Science ®Google Scholar
• Zhang GJ, Kimijima I, Onda M, Kanno M, Sato H, Watanabe T, Tsuchiya A, Abe R, Takenoshita S. Tamoxifen-induced apoptosis in breast cancer cells relates to down-regulation of bcl-2, but not bax and bcl-XL, without alteration of p53 protein levels. Clinical Cancer Res. 1999;5(10):2971–7.
   PubMed Web of Science ®Google Scholar
• Diel P, Smolnikar K, Michna H. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL‐2 than tamoxifen in MCF‐7 cells. Breast Cancer Res Treat. 1999;58(2):87–97. doi:10.1023/A:1006338123126
   PubMed Web of Science ®Google Scholar
• Montaner B, Navarro S, Piqué M, Vilaseca M, Martinell M, Giralt E, Gil J, Pérez-Tomás R. Prodigiosin from the supernatant of Serratia marcescens induces apoptosis in haematopoietic cancer cell lines. British J Pharmacol. 2000;131(3):585–93. doi:10.1038/sj.bjp.0703614
   PubMed Web of Science ®Google Scholar